Search

Author/Creator Kim, Kenneth

1. 1918. Impact of the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) on the Severity and Progression of COVID-19 Symptoms in the Phase 3 TACKLE Trial. (15th December 2022)

Authors:
Campos, Jesus Abraham Simón; Arbetter, Douglas; Montgomery, Hugh; Richard Hobbs, F D; Padilla, Francisco; Kim, Kenneth; Streicher, Katie; Templeton, Alison; Viani, Rolando M; Esser, Mark T
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial. (15th December 2022)

Authors:
Richard Hobbs, F D; Montgomery, Hugh; Padilla, Francisco; Kim, Kenneth; Simón Campos, Jesus Abraham; Arbetter, Douglas; Padilla, Kelly W; Reddy, Venkatesh P; Seegobin, Seth; Streicher, Katie; Viani, Rolando M; Koh, Gavin C KW; Esser, Mark T
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experience. Issue 1 (30th January 2021)

Authors:
Evans, Cory J; Olson, John M; Mondal, Bama Charan; Kandimalla, Pratyush; Abbasi, Ariano; Abdusamad, Mai M; Acosta, Osvaldo; Ainsworth, Julia A; Akram, Haris M; Albert, Ralph B; Alegria-Leal, Elitzander; Alexander, Kai Y; Ayala, Angelica C; Balashova, Nataliya S; Barber, Rebecca M; Bassi, Harmanji...
Editors:
Tennessen, J
Journal:
G3
Issue:
Volume 11:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers. Issue 3 (14th May 2013)

Authors:
Kosoglou, Teddy; Reyderman, Larisa; Tseng, Jack; Kumar, Bharath; Xuan, Fengjuan; Schiller, James; Meehan, Alan G.; Kim, Kenneth; Cutler, David L.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 2:Issue 3(2013:Jul.)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022)

Authors:
Montgomery, Hugh; Hobbs, F D Richard; Padilla, Francisco; Arbetter, Douglas; Templeton, Alison; Seegobin, Seth; Kim, Kenneth; Campos, Jesus Abraham Simón; Arends, Rosalinda H; Brodek, Bryan H; Brooks, Dennis; Garbes, Pedro; Jimenez, Julieta; Koh, Gavin C K W; Padilla, Kelly W; Streicher, Katie; V...
Journal:
Lancet
Issue:
Volume 10:Issue 10(2022)
Page Start:
985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. Issue 4 (April 2020)

Authors:
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N
Journal:
Lancet infectious diseases
Issue:
Volume 20:Issue 4(2020)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 12(2022)
Page Start:
1703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗